{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:38:08Z","timestamp":1780393088031,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.braindev.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T17:27:11Z","timestamp":1607102831000},"page":"411-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical experience on the use of perampanel in epilepsy among child neurologists in the Philippines"],"prefix":"10.1016","volume":"43","author":[{"given":"Bernadette","family":"Macrohon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Janette Resurreccion-De La Calzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benilda","family":"Sanchez-Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.braindev.2020.11.005_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","article-title":"The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist","volume":"56","author":"Patsalos","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.braindev.2020.11.005_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1756285615575696","article-title":"The AMPA receptor antagonist perampanel in the adjunctive treatment of partial-onset seizures: clinical trial evidence and experience","volume":"8","author":"Steinhoff","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.braindev.2020.11.005_b0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/ane.12529","article-title":"Perampanel for focal epilepsy: insights from early clinical experience","volume":"133","author":"Trinka","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2020.11.005_b0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2017.10.015","article-title":"On behalf of the Study 504 investigator group. A retrospective, multicenter study of perampanel given as monotherapy in routine clinical care in people with epilepsy","volume":"54","author":"Gil-Nagel","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2020.11.005_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebcr.2017.11.001","article-title":"Evaluation of perampanel as monotherapy for focal seizures: experience from open-label extension studies","volume":"9","author":"Kwan","year":"2018","journal-title":"Epilepsy Behav Case Rep"},{"issue":"11","key":"10.1016\/j.braindev.2020.11.005_b0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.braindev.2020.11.005_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13052-017-0368-6","article-title":"Current role of perampanel in pediatric epilepsy","volume":"43","author":"De Liso","year":"2017","journal-title":"Ital J Pediatr"},{"issue":"7","key":"10.1016\/j.braindev.2020.11.005_b0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/epi.13417","article-title":"Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: a randomized study evaluating behavior, efficacy, and safety","volume":"57","author":"Lagae","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2020.11.005_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejpn.2015.02.008","article-title":"Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled phase III randomized clinical studies and a combined extension study","volume":"19","author":"Rosenfeld","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.11.005_b0050","doi-asserted-by":"crossref","unstructured":"Biro A, Stephani U, Tarallo T, Bst T, Schlachter K, Fleger M, et al. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences. Neuropediatrics 2015;46:110\u20135.","DOI":"10.1055\/s-0035-1546276"},{"issue":"1","key":"10.1016\/j.braindev.2020.11.005_b0055","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1212\/NXG.0000000000000130","article-title":"Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1","volume":"3","author":"Ahrens-Nicklas","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.braindev.2020.11.005_b0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebcr.2017.05.004","article-title":"Efficacy of perampanel for controlling seizures and improving neurological dysfunction in a patient with dentorubralpallidoleysian atrophy (DRPLA)","volume":"8","author":"Shiraishi","year":"2017","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.braindev.2020.11.005_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1684\/epd.2016.0824","article-title":"One-year clinical experience of perampanel in spain: a multi- center study of efficacy and tolerability","volume":"18","author":"Garamundi-Ruiz","year":"2016","journal-title":"Epileptic Disord"},{"issue":"2","key":"10.1016\/j.braindev.2020.11.005_b0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.13279","article-title":"Cognitive effects of adjunctive perampanel for partial\u2010onset seizures: a randomized trial","volume":"57","author":"Meador","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2020.11.005_b0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/epi.13054","article-title":"Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2020.11.005_b0080","doi-asserted-by":"crossref","unstructured":"Shimabukuro K, Gbbon F, Kerstetter J, Tinsley C, Ashwal S. DRESS associated with perampanel administration in a child with drug-resistant epilepsy. Neurology 2014;83:2188\u20139.","DOI":"10.1212\/WNL.0000000000001052"},{"issue":"9","key":"10.1016\/j.braindev.2020.11.005_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.505","article-title":"Review of clinical studies of perampanel in adolescent patients","volume":"6","author":"Kim","year":"2016","journal-title":"Brain Behav"},{"key":"10.1016\/j.braindev.2020.11.005_b0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eplepsyres.2015.09.002","article-title":"Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: impact of mechanism of action and pharmacokinetics on clinical outcomes","volume":"117","author":"Kwan","year":"2015","journal-title":"Epilepsy Res"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420303168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420303168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:49:32Z","timestamp":1759952972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420303168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0387760420303168"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.11.005","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical experience on the use of perampanel in epilepsy among child neurologists in the Philippines","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}